Catalyst Wire Dossier Catalyst Wire Dossier

Coramitug

coramitug · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Coramitug, covering 2026-03-19 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis [Phase 3]

See pricing